Home » Topics » Regulatory » Patents

Patents
RSS

Kyowa Hakko reports antiestrogenic agents

Oct. 18, 1996

New immunosuppressants disclosed by Merck & Co.

Oct. 18, 1996

University of Texas discloses OMPs for immunotherapy

Oct. 18, 1996

Lyme disease vaccine claimed by University of Minnesota

Oct. 18, 1996

Magainin discloses LAP for microbial infections

Oct. 18, 1996

Washington University's MCP regulates complement activity

Oct. 18, 1996

University of North Carolina/Macronex research cytokine inhibitors

Oct. 18, 1996

Glaxo Wellcome claims antiviral agents with RNA virus specificity

Oct. 18, 1996

Pfizer discloses polycyclic ether antibiotics

Oct. 18, 1996

New antimigraine agents disclosed by Merck & Co.

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.